124 related articles for article (PubMed ID: 6994867)
1. Augmentation of immunity of line 10 hepatoma by BCG: comparison of different BCG preparations.
Bartlett GL; Kreider JW; Purnell DM; Katsilas DC
Cancer; 1980 Aug; 46(3):488-96. PubMed ID: 6994867
[TBL] [Abstract][Full Text] [Related]
2. Specific immunotherapy of established visceral micrometastases by BCG-tumor cell vaccine alone or as an adjunct to surgery.
Hanna MG; Peters LC
Cancer; 1978 Dec; 42(6):2613-25. PubMed ID: 728864
[TBL] [Abstract][Full Text] [Related]
3. Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin.
Minden P; Mathews HL
Cancer Res; 1980 Sep; 40(9):3214-7. PubMed ID: 6159072
[TBL] [Abstract][Full Text] [Related]
4. A specific vaccine effective against stage I and stage II malignant disease in guinea pigs. Effect of variations in preparations and storage.
Yarkoni E; Hunter JT; Sukumar S
Cancer Immunol Immunother; 1982; 14(2):92-5. PubMed ID: 6965232
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapeutic effectiveness of BCG inactivated by various modalities.
Kreider JW; Bartlett GL; Purnell DM
Cancer; 1980 Aug; 46(3):480-7. PubMed ID: 7397622
[TBL] [Abstract][Full Text] [Related]
6. Active specific immunotherapy of established micrometastases with BCG plus tumor cell vaccines: effective treatment of BCG side effects with isoniazid.
Hanna MG; Pollack VA; Peters LC; Hoover HC
Cancer; 1982 Feb; 49(4):659-64. PubMed ID: 7055781
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of guinea pig line 10 hepatoma with nonliving BCG cells in aqueous medium.
Bekierkunst A; Goren MB
Infect Immun; 1979 Jun; 24(3):817-20. PubMed ID: 381203
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally administered killed BCG cells and BCG cell walls.
Yarkoni E; Rapp HJ
Infect Immun; 1979 Sep; 25(3):1087-9. PubMed ID: 387592
[TBL] [Abstract][Full Text] [Related]
9. [Shared antigens between BCG and tumor cells--immunotherapy with BCG for mouse tumor].
Sasaki J; Kanda S; Sawamura D; Kamiya S; Inaba Y; Kawashima M
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1432-9. PubMed ID: 4015119
[TBL] [Abstract][Full Text] [Related]
10. Major histocompatibility complex class II antigen expression on leucocyte subpopulations in the draining lymph node and tumour in the early phase of bacillus-Calmette-Guérin-induced tumour regression.
Steerenberg PA; De Jong WH; Geerse E; De Graaf A; Scheper RJ; Den Otter W; Ruitenberg EJ
Cancer Immunol Immunother; 1991; 33(3):189-97. PubMed ID: 1828389
[TBL] [Abstract][Full Text] [Related]
11. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally injected emulsions containing heat-killed Nocardia rubra, Mycobacterium bovis (BCG) and Mycobacterium phlei.
Yarkoni E; Rapp HJ
Oncology; 1982; 39(5):314-8. PubMed ID: 7099513
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class II antigen expression during potentiation of line-10 tumor immunity after intralesional administration of bacillus Calmette-Guérin.
Steerenberg PA; De Jong WH; Geerse E; Aleva BJ; Besselink CM; Van Rens BT; Rutten VP; Poels LG; Scheper RJ; Den Otter W
Cancer Immunol Immunother; 1990; 32(2):95-104. PubMed ID: 1963114
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancer.
Witjes JA; Dalbagni G; Karnes RJ; Shariat S; Joniau S; Palou J; Serretta V; Larré S; di Stasi S; Colombo R; Babjuk M; Malmström PU; Malats N; Irani J; Baniel J; Cai T; Cha E; Ardelt P; Varkarakis J; Bartoletti R; Spahn M; Pisano F; Gontero P; Sylvester R
Urol Oncol; 2016 Nov; 34(11):484.e19-484.e25. PubMed ID: 27639776
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of postoperative metastases of 13762A rat mammary adenocarcinoma: comparative effectiveness of BCG substrains and methods of preparation.
Kreider JW; Bartlett GL; Purnell DM
Cancer; 1980 Aug; 46(3):500-7. PubMed ID: 7397623
[TBL] [Abstract][Full Text] [Related]
16. The effect of repeated BCG vaccine administration associated with surgery upon the growth of lung metastases in rats with transplantable Morris 5123 hepatoma.
Nowak HF; Zimnoch L; Jodczyk KJ; Cylwik B; Bernaczyk A; Duda D; Głowinska L; Popko J; Smietańska B
Neoplasma; 1981; 28(2):179-84. PubMed ID: 7254434
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. I. Synergism between BCG and line 10 tumor cells in the induction of an inflammatory response.
Key ME; Hanna MG
J Natl Cancer Inst; 1981 Oct; 67(4):853-61. PubMed ID: 6944552
[TBL] [Abstract][Full Text] [Related]
18. Influence of preexisting tumor immunity on Bacillus Calmette-Guérin immunotherapy of guinea pigs with both regional and disseminated tumor.
Jessup JM; Riggs CW; Hanna MG
Cancer Res; 1977 Aug; 37(8 Pt 1):2565-73. PubMed ID: 872084
[No Abstract] [Full Text] [Related]
19. Active specific immunotherapy of established micrometastasis: effect of cryopreservation procedures on tumor cell immunogenicity in guinea pigs.
Peters LC; Hanna MG
J Natl Cancer Inst; 1980 Jun; 64(6):1521-5. PubMed ID: 6990075
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of living BCG or BCG cell walls (CW) in the treatment of guinea pig hepatoma.
Zbar B; Hunter J; Rapp HJ; Canti G
Cancer; 1979 Feb; 43(2):484-91. PubMed ID: 421175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
